22 material Form 8-K filings that 21 companies we cover made with the SEC in August 2023, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Innoviva, Inc. announced that Stephen Basso has been appointed Chief Financial Officer, effective August 21, 2023. Basso previously served as CFO and Chief Operating Officer at Cybrexa Therapeutics and has more than 30 years of financial services and pharmaceutical industry experience, and the filing discloses his offer terms, including a $450,000 base salary, a 40% target bonus and an initial option grant of 150,000 shares subject to board approval.
Effective date of August 21, 2023; appointment announced August 25, 2023 in an 8-K and press release
Base salary of $450,000 and annual discretionary bonus with a 40% target of base salary
Initial grant of options to purchase 150,000 shares, subject to Board or Compensation Committee approval, plus a one-time $100,000 signing bonus
If terminated without cause or for good reason, 12 months of base salary continuation and accelerated vesting of unvested options if within 12 months after a change in control
KYN and Kayne Anderson NextGen Energy & Infrastructure (KMF) reset the record date for stockholder votes on their proposed combination, which is based on an amended and restated merger agreement dated April 24, 2023. Stockholders of record as of August 21, 2023 can vote at the special meeting, but the meeting date has not been set and will appear in a definitive joint proxy statement/prospectus that the funds expect to mail after an SEC review period.
Amended and Restated Agreement and Plan of Merger is dated April 24, 2023.
Record date for voting is the close of business on August 21, 2023.
The special meeting date has not been announced; a definitive joint proxy statement/prospectus is expected to be mailed after SEC review.
Effective August 14, 2023, the sponsor of the trust, ETF Managers Capital LLC, entered into a new Marketing Agent Agreement with Foreside Fund Services, LLC, which will handle distribution and marketing functions. The prior marketing agreement with ETFMG Financial LLC was terminated as of the same date, and ETFMG Financial will no longer provide services to the trust. The filing is an administrative change in service providers and does not report any financial results.
Effective date of the new agreement and termination: August 14, 2023
Foreside assists with marketing materials review, certain regulatory compliance, and processing of creation and redemption orders
Sponsor agreed to indemnify Foreside against certain liabilities, including under the Securities Act of 1933
Prior agreement dated March 1, 2017 with ETFMG Financial LLC, which was identified as the Distributor in each Fund's Prospectus, was terminated
Krystal Biotech disclosed that Andrew Orth, its Chief Commercial Officer, resigned and that his last day with the company was August 2, 2023. The filing does not give a reason for the departure or name a successor, and it does not describe any financial impact.
Andrew Orth, Chief Commercial Officer, resigned from his position.
Orth's last day with Krystal Biotech was August 2, 2023.
The filing does not name a replacement or state a reason for the resignation.
Merk Investments, sponsor of the VanEck Merk Gold Trust, said the Trust will change the benchmark used to value its gold from the LBMA PM Gold Price to the Solactive Gold Spot Index effective August 7, 2023. The change was first announced in May 2023 and the date has now been finalized, with the trustee, The Bank of New York Mellon, instructed to use the new index to calculate the Trust's net asset value from that date.
Benchmark changes from the LBMA PM Gold Price to the Solactive Gold Spot Index (SOLAGOLD)
Index Change Date is August 7, 2023
Change was first announced in May 2023; the date was finalized in this August 2, 2023 release
The Bank of New York Mellon, the trustee, will use SOLAGOLD to determine net asset value from the Index Change Date
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.